Modulation of the decrease in the seizure threshold of pentylenetetrazole in diazepam withdrawn mice by the...

Area of Science:

• Neuroscience
• Pharmacology
• Neurosteroid research

Background:

• Chronic diazepam treatment can lead to withdrawal symptoms, including seizures.
• Neurosteroids like alloTHDOC modulate GABAA receptor activity.
• Understanding withdrawal mechanisms is crucial for managing benzodiazepine dependence.

Purpose of the Study:

• To investigate the effect of alloTHDOC on pentylenetetrazole (PTZ)-induced seizures during diazepam withdrawal.
• To determine if alloTHDOC alters GABAA receptor sensitivity in diazepam-withdrawn mice.

Main Methods:

• Mice underwent chronic diazepam or vehicle treatment.
• Seizure thresholds were assessed using PTZ after drug discontinuation.
• The effect of alloTHDOC (10 and 20 mug/mouse, i.c.v.) was evaluated.
• Loss of righting reflex (LRR) was tested with other GABAA activators.

Main Results:

• Diazepam withdrawal significantly lowered the PTZ seizure threshold.
• Pretreatment with alloTHDOC attenuated the decrease in seizure threshold during withdrawal.
• AlloTHDOC did not affect seizure thresholds in vehicle-treated mice.
• No differences in LRR were observed between control and withdrawn mice for other GABAA activators.

Conclusions:

• AlloTHDOC demonstrates potential in suppressing diazepam withdrawal-induced seizures.
• Diazepam-withdrawn mice may exhibit enhanced sensitivity to alloTHDOC's GABAA receptor-mediated effects.
• These findings suggest a novel therapeutic avenue for managing benzodiazepine withdrawal.